Rytary ER 61.25 MG-245 MG cap 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FV715
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,338
Award facts
- Contract value 100% obligated
- $53,337.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $53,337.77 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of RYTARY ER 61.25 mg-245 mg capsules in quantities of 100, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order is non-set-aside and will be performed at the awardee's facility in Conshohocken, Pennsylvania. RYTARY (levodopa/carbidopa) is a extended-release medication used in the treatment of Parkinson's disease, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical products to support military healthcare systems and veteran medical programs.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to military healthcare programs worldwide. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor that serves as the parent organization. The contract reflects DLA's critical reliance on established vendors for pharmaceutical procurement to ensure consistent supply of prescription medications across the military health system.
Quick answers
Who was awarded contract SPE2DR26FV715?
SPE2DR26FV715 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV715 worth?
The government has obligated $53,338 on SPE2DR26FV715.
Is contract SPE2DR26FV715 an order under another contract?
Yes. SPE2DR26FV715 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV715 competed?
The extent of competition for SPE2DR26FV715 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award